6185.HK
CanSino Biologics Inc.
HKSEHKDEQUITY
Healthcare
DELAYED
Last price
29.48
▼ 2.58 (8.05%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
35.50
Prev close
32.06
Day high
31.98
Day low
28.08
Volume
24.32M
Market cap
$7.28B
P/E (TTM)
226.77
52W range
19.22 – 56.55
Day trading desk
Gap from prior close
+10.73%
Prior close 32.06
VWAP
29.96
-1.61% from price
Relative volume
62.50×
Unusually busy
Session range
26.42%
28.08 – 35.50
Position in range
19%
Near session low
ATR (14D)
2.44
8.27% of price
Prior day high
40.00
PDH
Prior day low
26.84
PDL
Bid / ask spread
—
Quote not published
Session volume
112.37M
Avg 1.80M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+19.35%
+20.7%
1M
+23.97%
+20.2%
3M
+6.89%
+3.8%
6M
-12.16%
-23.2%
YTD
-15.58%
-27.9%
1Y
-37.38%
-57.4%
3Y
+13.17%
-61.0%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 6185.HK open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
66.28M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 22, 25 | Wang (Jing) Director (Executive) |
SELL | 4.60K | $30.32K | Direct |
| Dec 18, 24 | Chao (Shou Bai) Chief Operating Officer |
BUY | 18.00K | $71.81K | Direct |
| Nov 27, 24 | Yu (Xuefeng) Chief Executive Officer |
BUY | 30.00K | $105.77K | Direct |
| Sep 26, 24 | Yu (Xuefeng) Chief Executive Officer |
BUY | 20.00K | $56.05K | Direct |
| Sep 9, 24 | Yu (Xuefeng) Chief Executive Officer |
BUY | 20.00K | $47.12K | Direct |
| Sep 9, 24 | Chao (Shou Bai) Chief Operating Officer |
BUY | 30.00K | $70.49K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
Chao (Shou Bai) |
Chief Operating Officer | 68.00K | Acquisition |
Wang (Jing) |
Director (Executive) | 14.20K | Sale |
Yu (Xuefeng) |
Chief Executive Officer | 11.69M | Acquisition |
Fundamentals
Market cap$7.28B
Enterprise value$6.03B
Revenue (TTM)$1.12B
Gross profit$844.83M
EBITDA$58.13M
Net income$-1.01M
EPS (TTM)$0.13
Free cash flow$-351.57M
Total cash$2.41B
Total debt$1.16B
Book value / share$23.26
Shares outstanding132.67M
Float159.89M
Short % of float—
Dividend yield—
Beta (5Y)1.22
Valuation & profitability ratios
Trailing P/E226.77
Forward P/E19.69
PEG ratio—
Price / sales—
Price / book1.27
EV / revenue5.38
EV / EBITDA103.82
Gross margin75.36%
Operating margin-15.19%
Profit margin-0.09%
Return on equity-0.02%
Return on assets-0.83%
Debt / equity23.59
Current ratio4.11
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $1.06B | $824.88M | $345.18M | $1.03B | +28.4% |
| Operating revenue | $1.06B | $824.88M | $345.18M | $1.03B | +28.4% |
| Cost of revenue | $260.13M | $244.43M | $1.22B | $1.22B | +6.4% |
| Gross profit | $799.26M | $580.45M | -$876.02M | -$186.61M | +37.7% |
| Research & development | $313.04M | $416.12M | $637.99M | $778.26M | -24.8% |
| Selling, general & admin | $589.83M | $563.41M | $647.85M | $544.68M | +4.7% |
| Total operating expense | $772.05M | $922.07M | $1.20B | $1.26B | -16.3% |
| Operating income | $27.21M | -$341.62M | -$2.08B | -$1.45B | +108.0% |
| Net interest income | -$5.16M | $3.71M | $35.71M | $24.10M | -239.0% |
| Pre-tax income | $21.74M | -$381.20M | -$1.98B | -$1.18B | +105.7% |
| Tax provision | -$6.13M | $2.47M | -$11.45M | -$219.24M | -348.7% |
| Net income | $27.87M | -$378.88M | -$1.48B | -$909.43M | +107.4% |
| Net income to common | $27.87M | -$378.88M | -$1.48B | -$909.43M | +107.4% |
| Basic EPS | 0.11 | -1.53 | -6.01 | -3.68 | +107.2% |
| Diluted EPS | 0.11 | -1.53 | -6.01 | -3.68 | +107.2% |
| EBIT | $61.34M | -$321.22M | -$1.91B | -$1.14B | +119.1% |
| EBITDA | $238.03M | -$109.84M | -$1.65B | -$946.30M | +316.7% |
| Basic shares | 247.01M | 246.85M | 246.77M | 247.02M | +0.1% |
| Diluted shares | 247.01M | 246.85M | 246.77M | 247.02M | +0.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $1.22B | $1.56B | $2.05B | $3.39B | -21.6% |
| Cash & short-term investments | $2.63B | $3.20B | $4.12B | $5.95B | -17.8% |
| Accounts receivable | $782.88M | $737.62M | $636.88M | $855.49M | +6.1% |
| Inventory | $338.31M | $280.52M | $350.65M | $677.78M | +20.6% |
| Total current assets | $3.84B | $4.28B | $5.18B | $7.73B | -10.4% |
| Property, plant & equipment | $2.62B | $2.66B | $3.04B | $3.08B | -1.2% |
| Goodwill & intangibles | $313.69M | $271.60M | $205.65M | $258.74M | +15.5% |
| Total assets | $7.18B | $7.96B | $9.32B | $11.47B | -9.8% |
| Total current liabilities | $1.08B | $1.77B | $2.59B | $2.94B | -38.9% |
| Current debt | $318.52M | $892.17M | $1.39B | $1.58B | -64.3% |
| Long-term debt | $956.95M | $1.10B | $1.07B | $878.01M | -12.9% |
| Total debt | $1.29B | $2.01B | $2.70B | $2.70B | -36.0% |
| Total liabilities | $2.22B | $3.05B | $4.03B | $4.22B | -27.0% |
| Retained earnings | -$471.44M | -$1.94B | -$1.56B | -$75.68M | +75.7% |
| Shareholder equity | $4.95B | $4.91B | $5.27B | $6.75B | +0.9% |
| Working capital | $2.76B | $2.51B | $2.59B | $4.79B | +9.8% |
| Net tangible assets | $4.64B | $4.64B | $5.07B | $6.49B | +0.0% |
| Shares issued | 247.04M | 247.45M | 247.45M | 247.45M | -0.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $21.74M | -$381.20M | -$1.98B | -$1.18B | +105.7% |
| Depreciation & amortisation | $176.69M | $211.38M | $269.05M | $196.36M | -16.4% |
| Stock-based compensation | $9.38M | $3.20M | $9.54M | $10.08M | +193.0% |
| Change in working capital | -$164.21M | -$115.79M | -$156.96M | -$1.48B | -41.8% |
| Operating cash flow | $77.86M | -$168.79M | -$916.25M | -$1.89B | +146.1% |
| Capital expenditure | -$243.90M | -$457.64M | -$610.47M | -$1.08B | +46.7% |
| Investing cash flow | $364.80M | $3.96M | -$441.62M | -$1.19B | +9,107.6% |
| Share buybacks | -$7.31M | -$6.96M | $0 | -$150.17M | -4.9% |
| Dividends paid | — | — | -$3.63M | -$193.93M | — |
| Financing cash flow | -$766.22M | -$334.18M | -$7.58M | $854.60M | -129.3% |
| Free cash flow | -$166.04M | -$626.42M | -$1.53B | -$2.96B | +73.5% |
| End cash position | $1.22B | $1.56B | $2.05B | $3.39B | -21.6% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
| Line item | 2025-12-31 | 2025-06-30 | YoY |
|---|---|---|---|
| Cash & equivalents | $1.22B | $1.13B | +8.1% |
| Cash & short-term investments | $2.63B | $3.24B | -19.0% |
| Accounts receivable | $782.88M | $660.33M | +18.6% |
| Inventory | $338.31M | $323.22M | +4.7% |
| Total current assets | $3.84B | $4.33B | -11.4% |
| Property, plant & equipment | $2.62B | $2.75B | -4.7% |
| Goodwill & intangibles | $313.69M | $210.74M | +48.9% |
| Total assets | $7.18B | $7.71B | -6.8% |
| Total current liabilities | $1.08B | $1.76B | -38.5% |
| Current debt | $318.52M | $1.01B | -68.4% |
| Long-term debt | $956.95M | $864.43M | +10.7% |
| Total debt | $1.29B | $1.89B | -31.8% |
| Total liabilities | $2.22B | $2.80B | -20.6% |
| Retained earnings | -$471.44M | -$1.95B | +75.8% |
| Shareholder equity | $4.95B | $4.90B | +1.0% |
| Working capital | $2.76B | $2.58B | +7.0% |
| Net tangible assets | $4.64B | $4.69B | -1.1% |
| Shares issued | 247.04M | 247.45M | -0.2% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Dec 2025 | 0.31 | — | — |
| Sep 2025 | -0.00 | 0.11 | +2,475.8% |
| Mar 2025 | -0.00 | -0.05 | -3,396.5% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | 0.47 | 1 | $1.43B | +34.8% |
| Next year | 1.28 | 1 | $1.79B | +27.6% |
Analyst targets & ownership
Mean target$50.63
High target$53.39
Low target$46.76
Implied upside71.73%
Analyst count4
ConsensusNONE
Strong buy / Buy1 / 3
Hold0
Sell / Strong sell0 / 0
Held by insiders26.83%
Held by institutions13.56%
Institutions holding51
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
25.83
+14.13% from price
SMA 20
24.66
+19.57% from price
SMA 50
23.69
+24.42% from price
SMA 100
26.70
+10.41% from price
SMA 200
32.04
-7.99% from price
EMA 12
26.06
+13.13% from price
EMA 26
25.00
+17.91% from price
EMA 50
24.97
+18.04% from price
RSI (14)
64.1
Neutral
MACD (12,26,9)
1.06
Hist 0.60
ATR (14)
2.44
8.27% of price
Realised vol 30D
103.6%
Annualised
Bollinger upper
29.06
20, 2σ
Bollinger lower
20.26
20, 2σ
50 / 200 cross
Death
23.69 vs 32.04
Trend bias
Below 200
-7.99%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.42
Less volatile than market
Correlation to SPY
-0.09
Largely independent
Realised vol 30D
103.6%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-62.2%
Peak to trough
Max drawdown 5Y
-95.0%
Peak to trough
ATR 14
2.44
8.27% of price
Beta (reported)
1.22
5Y monthly, from filing
Headlines
Trump takes starring role at Washington's IndyCar debut
AFP · 8m ago
SentinelOne Is Up 42% This Year and Reports Earnings on August 27. Should You Buy Before the Earnings Release?
Motley Fool · 8m ago
The Real Cost of Retiring in Myrtle Beach, South Carolina, on $2,500 a Month
24/7 Wall St. · 8m ago
Jim Cramer doubles down on his bold call on memory stocks
TheStreet · 15m ago
Dropbox's Chief Accounting Officer Had 5,854 Shares Withheld. Here's What Investors Should Know
Motley Fool · 16m ago
Trump takes a lap in 'the Beast' at Freedom 250 Grand Prix, waves green flag
USA TODAY · 17m ago
I make $32K/month from 3 simple, boring websites
Starter Story · 17m ago
Dow Jones Futures Due With Nvidia Earnings, Tariffs, Warsh In Focus
Investor's Business Daily · 18m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.